|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
2879
|
alphaFMAU
|
2879.0002: 2 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Reference standard for byproduct of [18F]FMAU and [11C]FMAU synthesis
(2′-deoxy-2′-[18F]fluoro-5-methyl-1-β-D-arabinofuranosyluracil)
|
|
|
|
|
|
|
|
|
Molar Mass: 260.22
|
|
|
C10H13FN2O5
|
|
|
[97672-34-9]
|
|
|
|
|
|
Colourless solid packaged in dark glass crimp cap vials.
|
|
|
|
|
|
|
|
|
Purity: > 95 %
|
|
|
Certificates:
CoA; 1H and 19F NMR spectra
|
|
|
Chemical Name:
CA index name: 2,4(1H,3H)-Pyrimidinedione, 1-[2-deoxy-2-fluoro-α-D-arabinofuranosyl]-5-methyl-
|
|
|
Synonymes:
α-FMAU, α-D-FMAU
|
|
|
Literature:
1. Mangner T.J. et al. Synthesis of 2′-deoxy-2′-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU, [18F]FIAU, as potential PET agents for imaging cellular proliferation. Nucl. Med. Biol. 2003, 30, 215-224.
|
|
|
2. Alauddin M.M. et al. Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model. Mol. Imaging 2004, 3, 76-84.
|
|
|
3. Alauddin M.M. et al. Synthesis and evaluation of 2′-deoxy-2′-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression. J. Nucl. Med. 2004, 45, 2063-2069
|
|
|
|
|
|
|
|
|
date of product catalogue issue:
05 April 2012
|